Acelyrin (NASDAQ:SLRN) Price Target Cut to $6.00 by Analysts at HC Wainwright

Acelyrin (NASDAQ:SLRN – Get Free Report) had its target price lowered by analysts at HC Wainwright from $8.00 to $6.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 71.92% from the […]

Leave a Reply

Your email address will not be published.

Previous post FY2026 EPS Estimates for Exelon Increased by Seaport Res Ptn
Next post Kraft Heinz (NASDAQ:KHC) Receives “In-Line” Rating from Evercore ISI